We have previously reported that the nucleoside analog 8-Cl-Ado possesses in vitro and in vivo activity against AML as a single agent and that it synergizes with the FLT3-ITD inhibitor quizartinib [15]. This evidence concerns the gene FLT3 and acute myeloid leukemia.